Cargando…

Identification of indications for albumin administration in septic patients with liver cirrhosis

BACKGROUND: Albumin infusion is the primary therapeutic strategy for septic patients with liver cirrhosis. Although recent studies have investigated the efficacy of albumin in the resuscitation stage of septic patients with liver cirrhosis, it remains unclear whether daily albumin administration can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Wenhan, Chen, Hui, Ma, Chencheng, Sun, Qin, Yang, Meicheng, Wang, Haofei, Peng, Qingyun, Wang, Jinlong, Zhang, Chen, Huang, Wei, Xie, Jianfeng, Huang, Yingzi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385943/ https://www.ncbi.nlm.nih.gov/pubmed/37507790 http://dx.doi.org/10.1186/s13054-023-04587-3

Ejemplares similares

Effects of hydrocortisone combined with vitamin C and vitamin B1 versus hydrocortisone alone on microcirculation in septic shock patients: A pilot study
por: Wang, Jinlong, et al.
Publicado: (2023)

The Survival of Septic Patients with Compensated Liver Cirrhosis Is Not Inferior to That of Septic Patients without Liver Cirrhosis: A Propensity Score Matching Analysis
por: Chang, Ya-Chun, et al.
Publicado: (2022)

Addition of terlipressin to norepinephrine in septic shock and effect of renal perfusion: a pilot study
por: Wang, Jinlong, et al.
Publicado: (2022)

Human albumin in the management of complications of liver cirrhosis
por: Bernardi, Mauro, et al.
Publicado: (2012)

Albumin administration in patients with cirrhosis: Current role and novel perspectives
por: de Mattos, Ângelo Zambam, et al.
Publicado: (2022)

Risk Factors and Disease Profile Associated with the Nucleic Acid Conversion Time of COVID-19 Patients Infected with the SARS-CoV-2 Omicron Variant in Fangcang Shelter Hospitals
por: Ma, Shaolei, et al.
Publicado: (2023)

Global burden of cirrhosis and liver cancer due to alcohol: the past, present, and the future
por: Xie, Chencheng, et al.
Publicado: (2023)

Use of Human Albumin Administration for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis: A Systematic Review and Meta-Analysis
por: Bai, Zhaohui, et al.
Publicado: (2022)

Immune Dysfunction and Albumin-Related Immunity in Liver Cirrhosis
por: Wilde, Benjamin, et al.
Publicado: (2019)

Validation of the Combined Model Based on Platelet Count and Albumin to Rule out High-Risk Varices in Liver Cirrhosis
por: Duan, Zhihui, et al.
Publicado: (2020)

Albumin Administration is Efficacious in the Management of Patients with Cirrhosis: A Systematic Review of the Literature
por: Zaccherini, Giacomo, et al.
Publicado: (2020)

Human albumin infusion strategy in liver cirrhosis: liberal or restrictive?
por: Bai, Zhaohui, et al.
Publicado: (2021)

Albumin Substitution in Decompensated Liver Cirrhosis: Don’t Forget Zinc
por: Grüngreiff, Kurt, et al.
Publicado: (2021)

Pseudocholinesterase and albumin in infants with cirrhosis
por: Popoviê, LJ, et al.
Publicado: (2000)

Effective albumin – A novel paradigm in the management of decompensated liver cirrhosis
por: Bernardi, Mauro
Publicado: (2023)

Neutrophil count to albumin ratio as a prognostic indicator for HBV‐associated decompensated cirrhosis
por: Han, Zhong, et al.
Publicado: (2021)

Albumin infusion may decrease the incidence and severity of overt hepatic encephalopathy in liver cirrhosis
por: Bai, Zhaohui, et al.
Publicado: (2019)

Leukocyte kinetics during the early stage acts as a prognostic marker in patients with septic shock in intensive care unit
por: Li, Qing, et al.
Publicado: (2021)

Sarcopenia as a prognostic indicator of liver cirrhosis
por: Kim, Sung‐Eun, et al.
Publicado: (2021)

The Roles of Albumin Levels in Head and Neck Cancer Patients with Liver Cirrhosis Undergoing Tumor Ablation and Microsurgical Free Tissue Transfer
por: Kao, Huang-Kai, et al.
Publicado: (2012)

The efficacy and safety profile of albumin administration for patients with cirrhosis at high risk of hepatorenal syndrome is dose dependent
por: Afinogenova, Yuliya, et al.
Publicado: (2015)

Serum lactate levels in cirrhosis and non-cirrhosis patients with septic shock
por: Tongyoo, Surat, et al.
Publicado: (2022)

Combined Albumin-Bilirubin Grade and Skeletal Muscle Mass as a Predictor in Liver Cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2019)

Albumin Binding Function: The Potential Earliest Indicator for Liver Function Damage
por: Ge, Penglei, et al.
Publicado: (2016)

Relationship of Hemodynamic Indices and Prognosis in Patients with Liver Cirrhosis
por: Baik, Soon Koo, et al.
Publicado: (2004)

Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis
por: Kerbert, Annarein J. C., et al.
Publicado: (2015)

Hematological Indices Are Useful in Predicting Complications of Liver Cirrhosis
por: Glisic, Tijana, et al.
Publicado: (2023)

Albumin in decompensated cirrhosis: new concepts and perspectives
por: Bernardi, Mauro, et al.
Publicado: (2020)

Assessment of Pyroptosis-Related Indicators as Potential Biomarkers and Their Association with Severity in Patients with Liver Cirrhosis
por: Wang, Ding, et al.
Publicado: (2021)

Value of Laboratory Indicators in Predicting Pneumonia in Symptomatic COVID-19 Patients Infected with the SARS-CoV-2 Omicron Variant
por: Zhu, Kongbo, et al.
Publicado: (2023)

The Right Liver Lobe Size/Albumin Concentration Ratio in Identifying Esophageal Varices among Patients with Liver Cirrhosis
por: Akram, Muhammad, et al.
Publicado: (2019)

Comparable Effect of Two-Step Versus Extended Infusions on the Pharmacokinetics of Imipenem in Patients with Sepsis and Septic Shock
por: Huang, Yingzi, et al.
Publicado: (2020)

Fluid Biomarkers for Predicting the Prognosis of Liver Cirrhosis
por: Chen, Si-Hai, et al.
Publicado: (2020)

Effects of Short-Term Human Albumin Infusion for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis
por: Bai, Zhaohui, et al.
Publicado: (2022)

Role of albumin in cirrhosis: from a hospitalist’s perspective
por: Walayat, Saqib, et al.
Publicado: (2017)

Curative effect of hepatic portal venous administration of autologous bone marrow in AIDS patients with decompensated liver cirrhosis
por: Liu, B, et al.
Publicado: (2013)

Circulating Th1 and Th2 Subset Accumulation Kinetics in Septic Patients with Distinct Infection Sites: Pulmonary versus Nonpulmonary
por: Xue, Ming, et al.
Publicado: (2020)

Emerging concepts in the care of patients with cirrhosis and septic shock
por: Jimenez, Jose Victor, et al.
Publicado: (2023)

D-Dimer-to-Albumin Ratio: A Novel Indicator to Predict Poor Outcomes in Patients with HBV-Associated Decompensated Cirrhosis
por: Sun, Lin, et al.
Publicado: (2022)

Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis
por: Basili, Stefania, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4h0q41ih4ufum7lvelq1233vo7